BNC 1322
Alternative Names: BNC-1322Latest Information Update: 15 Sep 2022
At a glance
- Originator BONAC Corporation
- Class Antivirals; RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research COVID 2019 infections
Most Recent Events
- 25 Aug 2022 Early research in COVID-2019 infections in Japan (Parenteral) before August 2022 (BONAC Corporation pipeline, August 2022)